Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cytosorbents Cor
(NQ:
CTSO
)
1.080
+0.040 (+3.85%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cytosorbents Cor
< Previous
1
2
3
4
5
Next >
Gold Moves Lower; US Crude Stocks Decline Last Week
December 28, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.27% to 37,758.26 while the NASDAQ rose 0.17% to 15,124.90....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 28, 2023
Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 28, 2023
Via
Benzinga
Recap: CytoSorbents Q3 Earnings
November 09, 2023
Via
Benzinga
A Preview Of CytoSorbents's Earnings
May 01, 2023
Via
Benzinga
Crude Oil Down 1%; US Wholesale Inventories Fall In November
December 28, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 50 points on Thursday. The Dow traded up 0.14% to 37,708.15 while the NASDAQ rose 0.19% to 15,127.17. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Dow Gains 50 Points; US Jobless Claims Rise To 218,000
December 28, 2023
U.S. stocks traded higher this morning, with the Dow Jones index gaining over 50 points on Thursday. Following the market opening Thursday, the Dow traded up 0.14% to 37,708.72 while the NASDAQ rose...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Blood Purification Focused CytoSorbents Trading Lower Today?
December 28, 2023
CytoSorbents Corporation (NASDAQ: CTSO) released an update on the initial data analysis of primary safety and effectiveness endpoints and the final independent Data and Safety Monitoring Board for the...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 28, 2023
Via
Benzinga
CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation
December 28, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering
December 13, 2023
Company insiders participated in the transaction with $435,000 of investment
From
CytoSorbents
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 17, 2023
Via
Benzinga
CytoSorbents Reports Third Quarter 2023 Financial and Operational Results
November 09, 2023
Q3 2023 Product sales grew 20% to $7.8M versus $6.5M in Q3 2022. Q3 2023 Total revenue was approximately $8.8M. The pivotal STAR-T trial remains blinded with database lock nearing and initial data...
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents to Report Third Quarter 2023 Operating and Financial Results
October 27, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents to Present at the 8th Annual Dawson James Conference
October 05, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry
September 27, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer
September 19, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorb with Ex Vivo Organ Perfusion: Transforming the Future of Solid Organ Transplantation
September 11, 2023
In the first human retrospective study, CytoSorb and ex vivo lung perfusion prior to lung transplant increased in-hospital and one-year survival
From
CytoSorbents
Via
GlobeNewswire
Brady, America's Car-Mart And 3 Stocks To Watch Heading Into Tuesday
September 05, 2023
With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
CytoSorbents Announces Resignation of Chief Financial Officer Alexander D’Amico
September 01, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
August 31, 2023
Advances CytoSorb as a Potentially Revolutionary Therapeutic Advance to Reverse Deadly Shock in Critically Ill and Cardiac Surgery Patients
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Reports Second Quarter 2023 Financial and Operational Results
August 01, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents to Report Second Quarter 2023 Operating and Financial Results
July 26, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Appoints Alexander D’Amico as Chief Financial Officer
July 19, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents And Humedics Announce Theranostic Collaboration in the Field of Liver Disease
July 11, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial
July 07, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents This Week to Host its Virtual Annual Stockholders Meeting and to Present at the Jefferies Healthcare Conference
June 05, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Reports First Quarter 2023 Results
May 02, 2023
Pivotal U.S. and Canada STAR-T Trial enrollment enters the last third of the study. Strong customer demand from Q4 2022 continued into Q1 2023, with current expectation of overall sales growth in 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents to Report First Quarter 2023 Operating and Financial Results
April 26, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents’ Pivotal STAR-T Trial Reaches Second Key Milestone With 80 Patients Enrolled
April 20, 2023
From
CytoSorbents
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.